MONDAY, July 8 (HealthDay News) -- Patients in remission from first-episode psychosis have better long-term recovery after reduction or discontinuation of antipsychotics rather than maintenance treatment, according to a study published online July 3 in JAMA Psychiatry.
Lex Wunderink, M.D., Ph.D., from Friesland Mental Health Services in Leeuwarden, Netherlands, and colleagues performed a seven-year follow-up of 103 patients with six months of remitted first-episode psychosis who had been randomly assigned to antipsychotic dose-reduction/discontinuation or maintenance treatment for 18 months.
The researchers found that patients in the dose-reduction/discontinuation group had a significantly higher recovery rate than the maintenance treatment group (40.4 versus 17.6 percent; odds ratio 3.49). The better recovery rates were associated with higher functional remission rates but not symptomatic remission rates.
"Dose reduction/discontinuation of antipsychotics during the early stages of remitted first-episode psychosis shows superior long-term recovery rates compared with the rates achieved with maintenance treatment," Wunderink and colleagues conclude.
The study was funded in part by an unconditional grant from Janssen-Cilag.
|Previous: Kidney Disease Significantly Reduces Life Expectancy in SLE||Next: Most Men Report No Shared Decision Making in PSA Screening|
Reader comments on this article are listed below. Review our comments policy.
Submit your opinion:
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community